Research Article
IL-10 Treatment Is Associated with Prohibitin Expression in the Crohn’s Disease Intestinal Fibrosis Mouse Model
Table 3
Protein expression of prohibitin and
-SMA (
).
| Time (wk) | Prohibitin | α-SMA | Control | IL-10KO mice | IL-10 treatment | Control | IL-10KO mice | IL-10 treatment |
| 12 | 7792.83 ± 666.11 | 2402.17 ± 936.33a | | 13328.83 ± 5075.65 | 23903.33 ± 5645.83a | | 14 | 7913.57 ± 474.08 | 1680.33 ± 367.01a | 3061.33 ± 473.84b | 15570.00 ± 5249.14 | 42154.50 ± 8708.8a | 27734.50 ± 5305.67b | 16 | 7618.77 ± 523.92 | 1259.83 ± 154.16a | 5491.83 ± 953.40b | 17103.50 ± 6522.18 | 50467.33 ± 5074.69a | 23245.00 ± 4178.07b |
|
|
, versus control group; b, versus IL-10KO mice group.
|